SS Innovations International (NASDAQ:SSII – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of SS Innovations International in a research note on Thursday, October 15th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell” and an average target price of $7.00.
Read Our Latest Research Report on SSII
SS Innovations International Stock Performance
Shares of SSII stock opened at $1.66 on Friday. The company has a market cap of $332.64 million, a P/E ratio of -27.67 and a beta of -1.52. SS Innovations International has a fifty-two week low of $1.26 and a fifty-two week high of $6.79. The stock has a 50 day simple moving average of $2.64 and a two-hundred day simple moving average of $3.72.
SS Innovations International (NASDAQ:SSII – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The business had revenue of $13.94 million for the quarter.
Insider Buying and Selling
In related news, CEO Srivastava Sudhir sold 33,333 shares of SS Innovations International stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $3.00, for a total value of $99,999.00. Following the completion of the transaction, the chief executive officer directly owned 108,520,928 shares in the company, valued at approximately $325,562,784. The trade was a 0.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Institutional Investors Weigh In On SS Innovations International
Institutional investors have recently made changes to their positions in the stock. Eversept Partners LP grew its stake in SS Innovations International by 46.2% during the first quarter. Eversept Partners LP now owns 110,157 shares of the company’s stock valued at $551,000 after acquiring an additional 34,799 shares in the last quarter. Inspire Investing LLC increased its holdings in SS Innovations International by 19.7% during the 3rd quarter. Inspire Investing LLC now owns 223,053 shares of the company’s stock worth $665,000 after acquiring an additional 36,756 shares during the period. Finally, 71 West Capital Partners bought a new stake in SS Innovations International during the 3rd quarter worth approximately $596,000.
SS Innovations International Company Profile
SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.
See Also
- Five stocks we like better than SS Innovations International
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
